Working together, we are all determined to create more medicines for pregnant women
Steve Hoare, the ABPI's Head of Safety and Quality, talks about how industry is trying to address the lack of medicines approved for pregnant women.
Read the full articleYou might also wanna read
Zhaohui Su Reports Rising Protocol Complexity Across 190,000 Clinical Trials
OncoDaily·1d ago
ABPI response to Life Sciences Competitiveness Indicators
ABPI·2d ago
Unlocking NHS data to increase recruitment into clinical trials will give the UK a competitive edge, says ABPI
ABPI·4d ago
ABPI welcomes new NHS research guidance
ABPI·4d ago
ABPI response to Lord O'Shaughnessy Review
ABPI·4d ago
10-year Moderna deal underlines UK potential for global life science leadership
ABPI·4d ago
Comments
Sign in to join the conversation.
No comments yet. Be the first.